TUCSON   520.748.4400


Bionomics is an Australian drug discovery and development company listed on the ASX. The company has several proprietary technology platforms called MultiCore®, Angene® and ionX® that are capable of generating drug candidates and targets in the therapeutic areas of cancer, anxiety, multiple sclerosis and epilepsy. Technology for these drug discovery platforms where acquired from Iliad Chemicals Pty Limited. Bionomics has advanced two in-house programs into late clinical trials for cancer and anxiety and has formed partnerships on other programs with companies such as Merck Serono and Athena Diagnostics.